Mediators of Inflammation

Mediators of Inflammation / 2007 / Article

Research Article | Open Access

Volume 2007 |Article ID 023296 | https://doi.org/10.1155/2007/23296

Alexandra Bukovská, Štefan Cikoš, Štefan Juhás, Gabriela Il’ková, Pavol Rehák, Juraj Koppel, "Effects of a Combination of Thyme and Oregano Essential Oils on TNBS-Induced Colitis in Mice", Mediators of Inflammation, vol. 2007, Article ID 023296, 9 pages, 2007. https://doi.org/10.1155/2007/23296

Effects of a Combination of Thyme and Oregano Essential Oils on TNBS-Induced Colitis in Mice

Received11 Jun 2007
Accepted22 Aug 2007
Published04 Oct 2007

Abstract

We examined the anti-inflammatory effects of the combination of thyme and oregano essential oil dietary administered at three concentrations (0.4% thyme and 0.2% oregano oils; 0.2% thyme and 0.1% oregano oils; 0.1% thyme and 0.05% oregano oils) on mice with TNBS-induced colitis. Treatment of colitic animals with the essential oils decreased the mRNA levels of pro-inflammatory cytokines IL-1β, IL-6, GM-CSF, and TNFα, especially after application of the medium dose. The medium dose of the essential oils significantly lowered the amount of IL-1β and IL-6 proteins too. Moreover, administration of the medium dose decreased the mortality rate, accelerated the body weight gain recovery, and reduced the macroscopic damage of the colonic tissue. Our results indicate that combined treatment with appropriate concentrations of thyme and oregano essential oils can reduce the production of proinflammatory cytokines, and thereby attenuate TNBS-induced colitis in mice.

References

  1. J. Panés, “Inflammatory bowel disease: pathogenesis and targets for therapeutic interventions,” Acta Physiologica Scandinavica, vol. 173, no. 1, pp. 159–165, 2001. View at: Publisher Site | Google Scholar
  2. Y. H. Kho, M. Oudkerk Pool, F. G. A. Jansman, and J. W. Harting, “Pharmacotherapeutic options in inflammatory bowel disease: an update,” Pharmacy World & Science, vol. 23, no. 1, pp. 17–21, 2001. View at: Publisher Site | Google Scholar
  3. T. Hong, G.-B. Jin, G. Yoshino et al., “Protective effects of Polygalae root in experimental TNBS-induced colitis in mice,” Journal of Ethnopharmacology, vol. 79, no. 3, pp. 341–346, 2002. View at: Publisher Site | Google Scholar
  4. K. Sugimoto, H. Hanai, K. Tozawa et al., “Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice,” Gastroenterology, vol. 123, no. 6, pp. 1912–1922, 2002. View at: Publisher Site | Google Scholar
  5. S. Maity, A. Ukil, S. Karmakar et al., “Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis,” European Journal of Pharmacology, vol. 470, no. 1-2, pp. 103–112, 2003. View at: Publisher Site | Google Scholar
  6. A. Ukil, S. Maity, S. Karmakar, N. Datta, J. R. Vedasiromoni, and P. K. Das, “Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis,” British Journal of Pharmacology, vol. 139, no. 2, pp. 209–218, 2003. View at: Publisher Site | Google Scholar
  7. K. H. Kwon, A. Murakami, T. Tanaka, and H. Ohigashi, “Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression,” Biochemical Pharmacology, vol. 69, no. 3, pp. 395–406, 2005. View at: Publisher Site | Google Scholar
  8. S. V. Popov, R. G. Ovodova, P. A. Markov, I. R. Nikitina, and Y. S. Ovodov, “Protective effect of comaruman, a pectin of cinquefoil Comarum palustre L., on acetic acid-induced colitis in mice,” Digestive Diseases and Sciences, vol. 51, no. 9, pp. 1532–1537, 2006. View at: Publisher Site | Google Scholar
  9. Y.-H. Zhou, J.-P. Yu, Y.-F. Liu et al., “Effects of Ginkgo biloba extract on inflammatory mediators (SOD, MDA, TNF-a, NF-?Bp65, IL-6) in TNBS-induced colitis in rats,” Mediators of Inflammation, vol. 2006, Article ID 92642, 9 pages, 2006. View at: Publisher Site | Google Scholar
  10. G. Rogler and T. Andus, “Cytokines in inflammatory bowel disease,” World Journal of Surgery, vol. 22, no. 4, pp. 382–389, 1998. View at: Publisher Site | Google Scholar
  11. S. Wirtz and M. F. Neurath, “Animal models of intestinal inflammation: new insights into the molecular pathogenesis and immunotherapy of inflammatory bowel disease,” International Journal of Colorectal Disease, vol. 15, no. 3, pp. 144–160, 2000. View at: Publisher Site | Google Scholar
  12. P. L. Bertevello, A. F. Logullo, S. Nonogaki et al., “Immunohistochemical assessment of mucosal cytokine profile in acetic acid experimental colitis,” Clinics, vol. 60, no. 4, pp. 277–286, 2005. View at: Google Scholar
  13. D. Raddatz, M. Bockemühl, and G. Ramadori, “Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome,” European Journal of Gastroenterology & Hepatology, vol. 17, no. 5, pp. 547–557, 2005. View at: Publisher Site | Google Scholar
  14. H. M. Alzuherri, C. J. Woodall, and C. J. Clarke, “Increased intestinal TNF-α, IL-1β and IL-6 expression in ovine paratuberculosis,” Veterinary Immunology and Immunopathology, vol. 49, no. 4, pp. 331–345, 1996. View at: Publisher Site | Google Scholar
  15. S. Fournout, C. M. Dozois, M. Odin et al., “Lack of a role of cytotoxic necrotizing factor 1 toxin from Escherichia coli in bacterial pathogenicity and host cytokine response in infected germfree piglets,” Infection and Immunity, vol. 68, no. 2, pp. 839–847, 2000. View at: Publisher Site | Google Scholar
  16. T. Brasseur, “Etudes botaniques, phytochimiques et pharmacologiques consacrées au thym,” Journal de Pharmacie de Belgique, vol. 38, no. 5, pp. 261–272, 1983. View at: Google Scholar
  17. T. Essawi and M. Srour, “Screening of some Palestinian medicinal plants for antibacterial activity,” Journal of Ethnopharmacology, vol. 70, no. 3, pp. 343–349, 2000. View at: Publisher Site | Google Scholar
  18. K. Miura, H. Kikuzaki, and N. Nakatani, “Antioxidant activity of chemical components from sage (Salvia officinalis L.) and thyme (Thymus vulgaris L.) measured by the oil stability index method,” Journal of Agricultural and Food Chemistry, vol. 50, no. 7, pp. 1845–1851, 2002. View at: Publisher Site | Google Scholar
  19. K. M. Soliman and R. I. Badeaa, “Effect of oil extracted from some medicinal plants on different mycotoxigenic fungi,” Food and Chemical Toxicology, vol. 40, no. 11, pp. 1669–1675, 2002. View at: Publisher Site | Google Scholar
  20. M. Hudaib, E. Speroni, A. M. Di Pietra, and V. Cavrini, “GC/MS evaluation of thyme (Thymus vulgaris L.) oil composition and variations during the vegetative cycle,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 4, pp. 691–700, 2002. View at: Publisher Site | Google Scholar
  21. P. C. Braga, M. Dal Sasso, M. Culici, T. Bianchi, L. Bordoni, and L. Marabini, “Anti-inflammatory activity of thymol: inhibitory effect on the release of human neutrophil elastase,” Pharmacology, vol. 77, no. 3, pp. 130–136, 2006. View at: Publisher Site | Google Scholar
  22. Y. Suzuki and H. Furuta, “Stimulation of guinea pig neutrophil superoxide anion-producing system with thymol,” Inflammation, vol. 12, no. 6, pp. 575–584, 1988. View at: Publisher Site | Google Scholar
  23. R. Aeschbach, J. Löliger, B. C. Scott et al., “Antioxidant actions of thymol, carvacrol, 6-gingerol, zingerone and hydroxytyrosol,” Food and Chemical Toxicology, vol. 32, no. 1, pp. 31–36, 1994. View at: Publisher Site | Google Scholar
  24. N. Didry, L. Dubreuil, and M. Pinkas, “Activity of thymol, carvacrol, cinnamaldehyde and eugenol on oral bacteria,” Pharmaceutica Acta Helvetiae, vol. 69, no. 1, pp. 25–28, 1994. View at: Publisher Site | Google Scholar
  25. M. E. Venturini, D. Blanco, and R. Oria, “In vitro antifungal activity of several antimicrobial compounds against Penicillium expansum,” Journal of Food Protection, vol. 65, no. 5, pp. 834–839, 2002. View at: Google Scholar
  26. A. Mahmoud, “Antifungal action and anti aflatoxigenic properties of some essential oil constituents,” Letters in Applied Microbiology, vol. 19, pp. 110–113, 1994. View at: Google Scholar
  27. S. Fujisawa and Y. Kadoma, “Effect of phenolic compounds on the polymerization of methyl methacrylate,” Dental Materials, vol. 8, no. 5, pp. 324–326, 1992. View at: Publisher Site | Google Scholar
  28. M. H. Alma, A. Mavi, A. Yildirim, M. Digrak, and T. Hirata, “Screening chemical composition and in vitro antioxidant and antimicrobial activities of the essential oils from Origanum syriacum L. growing in Turkey,” Biological & Pharmaceutical Bulletin, vol. 26, no. 12, pp. 1725–1729, 2003. View at: Publisher Site | Google Scholar
  29. C. C. Arcila-Lozano, G. Loarca-Piña, S. Lecona-Uribe, and E. González De Mejía, “Oregano: properties, composition and biological activity,” Archivos Latinoamericanos de Nutricion, vol. 54, no. 1, pp. 100–111, 2004. View at: Google Scholar
  30. H. Tian and D. M. Lai, “Analysis on the volatile oil in Origanum vulgare,” Zhongyaocai, vol. 29, no. 9, pp. 920–921, 2006. View at: Google Scholar
  31. B. Bozin, N. Mimica-Dukic, N. Simin, and G. Anackov, “Characterization of the volatile composition of essential oils of some lamiaceae spices and the antimicrobial and antioxidant activities of the entire oils,” Journal of Agricultural and Food Chemistry, vol. 54, no. 5, pp. 1822–1828, 2006. View at: Publisher Site | Google Scholar
  32. K. Horošová, D. Bujňáková, and V. Kmet, “Effect of oregano essential oil on chicken Lactobacilli and E. coli,” Folia Microbiologica, vol. 51, no. 4, pp. 278–280, 2006. View at: Google Scholar
  33. J. L. Wallace, W. K. MacNaughton, G. P. Morris, and P. L. Beck, “Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease,” Gastroenterology, vol. 96, no. 1, pp. 29–36, 1989. View at: Google Scholar
  34. Š. Juhás, Š. Cikoš, S. Czikková et al., “Effects of borneol and thymoquinone on TNBS induced colitis in mice,” submitted to Folia Biologica. View at: Google Scholar
  35. J. Vandesompele, K. De Preter, F. Pattyn et al., “Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes,” Genome Biology, vol. 3, no. 7, pp. research0034.1–research0034.11, 2002. View at: Publisher Site | Google Scholar
  36. M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976. View at: Publisher Site | Google Scholar
  37. A. A. Parikh, A. L. Salzman, J. E. Fischer, C. Szabó, and P.-O. Hasselgren, “Interleukin-1β and interferon-γ regulate interleukin-6 production in cultured human intestinal epithelial cells,” Shock, vol. 8, no. 4, pp. 249–255, 1997. View at: Google Scholar
  38. E. S. Hungness, T. A. Pritts, G.-J. Luo, X. Sun, C. G. Penner, and P.-O. Hasselgren, “The transcription factor activator protein-1 is activated and interleukin-6 production is increased in interleukin-1 β-stimulated human enterocytes,” Shock, vol. 14, no. 3, pp. 386–391, 2000. View at: Google Scholar
  39. S. Aydin, A. A. Başaran, and N. Başaran, “Modulating effects of thyme and its major ingredients on oxidative DNA damage in human lymphocytes,” Journal of Agricultural and Food Chemistry, vol. 53, no. 4, pp. 1299–1305, 2005. View at: Publisher Site | Google Scholar
  40. F. Dušan, S. Marián, D. Katarína, and B. Dobroslava, “Essential oils—their antimicrobial activity against Escherichia coli and effect on intestinal cell viability,” Toxicology in Vitro, vol. 20, no. 8, pp. 1435–1445, 2006. View at: Publisher Site | Google Scholar
  41. S. Santoyo, S. Cavero, L. Jaime, E. Ibañez, F. J. Señoráns, and G. Reglero, “Supercritical carbon dioxide extraction of compounds with antimicrobial activity from Origanum vulgare L.: determination of optimal extraction parameters,” Journal of Food Protection, vol. 69, no. 2, pp. 369–375, 2006. View at: Google Scholar
  42. B. Adam, T. Liebregts, J. Best et al., “A combination of peppermint oil and caraway oil attenuates the post-inflammatory visceral hyperalgesia in a rat model,” Scandinavian Journal of Gastroenterology, vol. 41, no. 2, pp. 155–160, 2006. View at: Publisher Site | Google Scholar
  43. Z. Sun and R. Andersson, “NF-κB activation and inhibition: a review,” Shock, vol. 18, no. 2, pp. 99–106, 2002. View at: Google Scholar
  44. Y. Deguchi, A. Andoh, O. Inatomi et al., “Curcumin prevents the development of dextran sulfate sodium (DSS)-induced experimental colitis,” to apper in Digestive Diseases and Sciences. View at: Publisher Site | Google Scholar
  45. A. Murakami, K. Matsumoto, K. Koshimizu, and H. Ohigashi, “Effects of selected food factors with chemopreventive properties on combined lipopolysaccharide- and interferon-γ-induced IκB degradation in RAW264.7 macrophages,” Cancer Letters, vol. 195, no. 1, pp. 17–25, 2003. View at: Publisher Site | Google Scholar
  46. Y. L. Lin, S. H. Tsai, S. Y. Lin-Shiau, C. T. Ho, and J. K. Lin, “Theaflavin-3,3-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-κB in macrophages,” European Journal of Pharmacology, vol. 367, no. 2-3, pp. 379–388, 1999. View at: Publisher Site | Google Scholar
  47. K. Stalińska, A. Guzdek, M. Rokicki, and A. Koj, “Transcription factors as targets of the anti-inflammatory treatment. A cell culture study with extracts from some Mediterranean diet plants,” Journal of Physiology and Pharmacology, vol. 56, supplement 1, pp. 157–169, 2005. View at: Google Scholar

Copyright © 2007 Alexandra Bukovská et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views722
Downloads1148
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.